The effectiveness of psychodynamic psychotherapies: an update

The effectiveness of psychodynamic psychotherapies:an updatePETER FONAGY Research Department of Clinical, Educational and Health Psychology, University College London, and The Anna Freud Centre, London, UK This paper provides a comprehensive review of outcome studies and meta-analyses of effectiveness studies of psychodynamic therapy (PDT)for the major categories of mental disorders. Comparisons with inactive controls (waitlist, treatment as usual and placebo) generally but byno means invariably show PDT to be effective for depression, some anxiety disorders, eating disorders and somatic disorders. There is littleevidence to support its implementation for post-traumatic stress disorder, obsessive-compulsive disorder, bulimia nervosa, cocaine depen-dence or psychosis. The strongest current evidence base supports relatively long-term psychodynamic treatment of some personality disorders,particularly borderline personality disorder. Comparisons with active treatments rarely identify PDT as superior to control interventions andstudies are generally not appropriately designed to provide tests of statistical equivalence. Studies that demonstrate inferiority of PDT toalternatives exist, but are small in number and often questionable in design. Reviews of the field appear to be subject to allegiance effects.
The present review recommends abandoning the inherently conservative strategy of comparing heterogeneous "families" of therapies for het-erogeneous diagnostic groups. Instead, it advocates using the opportunities provided by bioscience and computational psychiatry to creative-ly explore and assess the value of protocol-directed combinations of specific treatment components to address the key problems of individualpatients.
Key words: Psychodynamic psychotherapy, psychoanalysis, depression, anxiety disorders, eating disorders, somatic disorders, personalitydisorders (World Psychiatry 2015;14:137–150) Psychodynamic therapy (PDT) is on the retreat around the py as "evidence-based" (e.g., practice-based evidence) (23).
world in the face of critique of its scientific credibility. Empiri- However, it is misguided to deny that RCTs are key to estab- cally substantiated clinical judgement underpins professional lishing the validity of a therapeutic modality.
accountability and transparency in health care and increas- The history of medicine is littered with interventions that ingly so in mental health (1). One would therefore expect em- did remarkable duty as therapies and yet, when subjected to pirically supported therapies to gradually replace treatment RCT methodology, were shown either to have no benefit over as usual in everyday clinical care (2-5). Many outside the alternative treatments or even to prevent the patient from cognitive-behavioural therapy (CBT) community have ob- benefitting, in terms of effect size or speed, from a superior jected to this, raising concerns about the generalizability of intervention. Perhaps the most dramatic example is the RCT findings from randomized controlled trials (RCTs) (6).
that ended 100 years of radical mastectomies for breast carci- The issue of external validity of RCTs in the context of noma only 30 years ago. The study showed that half a million health care policy was recently exposed to philosophical women who had been subjected to disabling, mutilating oper- scrutiny (7), leading to the suggestion that the key issue may ations, performed with the best of intentions on the basis of a not be the theory-driven question of whether an intervention fallacious theory about how carcinoma spreads, could have works, but the implementation question "Will it work for had equally good outcomes with lumpectomies (24).
us?". For example, multisystemic therapy for conduct disor- Empirical knowledge in psychological therapies is multi- der is supported by trials in the U.S. and Norway, but these faceted and complex, and requires sophistication in the scru- results were not replicated in Sweden and Canada (8-19).
tiny of research data. While critical reviews that summarize Along with other researchers, we have argued that, in or synthesize a body of research are not without value, they order for a treatment to be considered as empirically sup- also have major limitations. They rely on the statistical signif- ported, evidence beyond that provided by RCTs is required icance of a study to determine an intervention's efficacy, yet (20,21). However, this does not imply, as many have as- statistical significance is primarily determined by sample sumed, that RCTs can be replaced by methods that do not size. Meta-analyses can pool multiple studies where each comply with Mill's "method of difference" maxim (stating has low statistical power (a pervasive problem in psychother- that where you have one situation that leads to an effect, apy research), but are potentially misleading when the RCTs and another which does not, and the only difference is the being aggregated are not homogeneous in terms of the target presence of a single factor in the first situation, you can infer population, the treatment method and the outcome mea- this factor as the cause of the effect) (22).
sures. This is often the case for trials of PDT.
Some have argued that not only are RCTs for psycho- A recent meta-review of 61 meta-analyses covering 21 therapy flawed because of issues of generalizability, but also psychiatric disorders containing 852 trials and 137,126 par- that there are alternative ways of establishing psychothera- ticipants yielded slightly larger effect sizes for psychotherapy (0.58; 95% CI: 0.42 to 0.76) than pharmacotherapy (0.40; fied by the work of those around the boundaries of both 95% CI: 0.28 to 0.52) studies (25), but the applicability of domains (33-36). The common distinction between inter- these figures is brought into question by the null results from pretive and supportive approaches (37) speaks to a clinical dichotomy that existed 30-40 years ago, but hardly applies The limitations of meta-analyses have generated concern today. Certain manualized treatments are labelled as psy- among a number of reviewers (26,27) that undue weight is chodynamic (38,39), but a thorough content analysis of given to heterogeneous small-scale studies, which are con- these remains to be done. The pragmatic approach adopted sidered in preference to well-designed and well-conducted in this review has been to use self-declared allegiance as the RCTs that converge in their results. While hard-pressed guiding principle as to what constitutes PDT.
readers may understandably wish to take an intellectual This review focuses on effectiveness and ignores ques- short-cut to a pooled effect size rather than considering tions of mechanism and treatment process. This was, again, individual investigations, it is important to remember that a decision of expedience given the space limitations and the meta-analyses lack individual patient data – they are based wish to provide a comprehensive survey. The literature on response rates and mean values. This masks important search on which this contribution depends was based on heterogeneity that is often revealed by careful scrutiny of the methodology evolved for two previous large-scale sur- veys (20,40) and involved a computer search of all major This review has opted to prioritize individual studies. The databases using 100 terms referring to different aspects of key limitation of small studies is the so-called "file drawer" mental health problems and 11 terms describing psycho- problem. Insufficient patients are sampled in small studies. As therapy (the search algorithm and full inclusion criteria are a consequence, relying on underpowered studies means that available on request). Studies were selected if they reported there is a risk that the likely effectiveness of a therapy is over- outcomes that were directly related to the disorder or to stated simply because a study with the same sample size but intermediate variables. The review is limited to experimental chance negative findings is unlikely to have been published.
designs involving some degree of random assignment.
Further, it is important to recognize that the absence of a significant difference between two conditions in a studyshould not be considered evidence for equivalence. The lat- ter requires a different statistical procedure and a larger sam-ple size than the so-called "superiority trials" which most psychotherapy trials are (28). Lack of significant differencedoes not mean that two interventions are equally effective, Several studies have compared PDT to waitlist (41,42), but only that it is impossible to rule out their equivalence placebo (43-46) or usual care controls (47-50) in the short- (29). A confident statement of superiority requires a trial term treatment of depression. The results are mixed, with with at least 50 individuals per arm for a medium effect size some favouring PDT (41-43,47,49,51) while others report (30). Equivalence trials are expected to have sample sizes no superiority to controls (44-46,48,50).
several times larger. Sadly, few of the trials which are re- A number of these studies are methodologically too weak viewed here meet this elementary criterion.
to permit definitive conclusions, either due to small sample Finally, how do we define psychodynamic psychotherapy? size (41-43,50) or because their implementation of PDT fails A recent meta-analysis likened the family of psychodynamic to meet criteria (52) for a bona fide treatment (44,48).
therapies to an actual, if somewhat dysfunctional, family Among the good studies, results are still mixed. Some stud- whose many members hardly spoke to each other and some- ies report medium effect sizes: 20.57 (95% CI: 20.99 to times even spoke different languages (31). This review uses a 20.14) (47) and 20.53 (95% CI: 20.92 to 20.13) (49). Per- broad definition of psychodynamic treatment as a stance tak- haps the most rigorous study comparing supportive expres- en to human subjectivity that is inclusive and aimed at a com- sive therapy with placebo medication reported no superior prehensive understanding of the interplay between aspects effects at the end of treatment on either depression (45) or of the individual's relationship with his/her environment, quality of life (46). However, a recent well-conducted study whether external or internal (32). It refers to the extraordi- of women with depressive disorders and breast cancer found nary human potential for dynamic self-alteration and self- that significantly more of the PDT group achieved remission correction. This definition incorporates a developmental from depression than the usual care group (44% vs. 23%) perspective, and assumes limitations on conscious influence, (53). An RCT of a mixed anxiety and depression group also ubiquity of conflict, internal representation of relationships, reported favourable post-treatment results for PDT on clini- mental defences, and that complex meanings can be attached cian and self-report measures (54).
to experience (32).
An intriguing meta-analysis of studies carried out in China The boundaries of PDT have become blurred over recent lists six controlled trials that reported substantial treatment decades by changes in both CBT approaches and psychody- success from psychodynamic psychotherapy as an adjunct to namic theory and technique, leading to increasing conver- medication and conventional nursing in the treatment of gence of both understanding and clinical methods, exempli- depression in patients with Parkinson's disease (55).
World Psychiatry 14:2 - June 2015 Since in clinical practice psychological therapies for reporting too limited to permit reliable inferences about depression are mostly offered in combination with medi- equivalence or even superiority (76-82). If CBT is superior cation, the potential value added by brief dynamic thera- to PDT, it is so only in very brief (8-session) implementa- py is a key question for practitioners. A well-constructed, tions (77). PDT and solution-focused therapy appear com- appropriately powered RCT found combined treatment parable in effectiveness (83).
to be more acceptable (reducing refusal and premature A recently advanced innovative approach used the Inter- termination of medication) and associated with higher net to deliver PDT based on a self-help manual in a pro- recovery rates (41% vs. 59%) (56). These findings were gramme lasting 10 weeks. Compared to a structured support confirmed for self-reported depression and quality of life condition, recovery rates of 35% vs. 9% were reported, which outcomes, but not for clinician-rated outcomes (57). A were maintained at 10-month follow-up (84). A second trial further smaller study comparing clomipramine with or based on a different model also yielded good outcomes com- without PDT reported reduced depression, lower hospi- pared to online therapist support without treatment modules talization rates, better work adjustment and better global in a mixed mood and anxiety disorder population (85).
functioning in the combined treatment group (58). Acombined analysis of three RCTs (56,59,60), in whichdata were pooled to enable contrasts between pharmaco- therapy alone and combination treatment, yielded betterobserver-rated and self-reported outcomes in terms of In normal practice, PDT is often offered as a long-term remission and response rates at treatment termination for (50 sessions or more) treatment. However, only a handful of combination treatments (61).
studies have explored the effectiveness of long-term PDT.
There may be moderators of the superior effect of com- The Helsinki study showed long-term PDT to be inferior bination treatments. So far, unreplicated findings suggest to short-term PDT initially, but superior after 3-year follow- that PDT may be particularly indicated if depression is up (86-88). In an intriguing comparison between intensive accompanied by personality disorder (62,63) or child- long-term PDT (psychoanalysis), long-term PDT and short- hood trauma (64), and findings are restricted to long-term term PDT, psychoanalysis was initially inferior to both other follow-ups (42,65,66). Dose-effect relations associated therapies, but was more effective at 5-year follow-up (89).
with the length of therapy (8 vs. 16 sessions) have not A large-scale naturalistic study randomized 272 depressed been found for combination treatments (59).
patients to unmanualized long-term PDT, fluoxetine or their When pharmacotherapy is contrasted head-to-head with combination for 24 months (51). Long-term PDT on its own PDT, studies fail to identify differential effects (45,46,67,68).
or in combination was more effective in reducing depression Adding pharmacotherapy to PDT brings equivocal benefit scores than fluoxetine alone, with a medium effect size.
(60), an important observation in the light of consistent find- A study in which participants with major depressive dis- ings of patient preference for PDT (69). A meta-analysis order were randomized to psychoanalysis or long-term PDT comparing psychotherapies to treatment with selective sero- found significant superiority of psychoanalysis on self-rated tonin reuptake inhibitors demonstrated that the former were measures of depression at 3-year follow-up, but no differen- comparable to medication and that PDT was as efficacious ces at 1 and 2 years (90). A quasi-experimental comparison as other therapies. However, psychotherapies that were not found psychoanalysis but not long-term PDT to be superior bona fide (i.e., those delivered by professionals without sub- to CBT on measures of depression at 3 year follow-up (91).
stantial training in psychotherapy) had significantly worse A recently completed study of 18 months of once-weekly outcomes (70).
psychoanalytic psychotherapy for patients with two previous Several high-quality trials reported comparisons between documented treatment failures reported the psychotherapy CBT and PDT. A well-powered equivalence trial (N5341) to be superior to U.K. practice guidelines-based treatment, reported no observer-rated, patient-rated or therapist-rated but superiority was not apparent until 2 years after the end of differences at treatment termination or follow-up, although treatment (92).
overall the remission rate was low at 22.7% (71-73). Anothertrial found PDT, but not counselling or CBT, to be superiorto a control in reducing the rate of postnatal depression at termination (49), although the treatments were equivalent atshort-term and long-term follow-up. By contrast, an RCT of Meta-analytic findings on the whole reveal large pre-post 291 inpatients reported that CBT was equally effective in treatment effects (93,94) for PDT maintained at 1-year those selected for CBT or PDT, while PDT benefitted only follow-up, with medium effect sizes indicating superiority to those who were specifically selected for that treatment (74).
inactive controls (31,95) but either no difference (31) or Consequently, CBT was superior for the randomly rather slight inferiority (94) in relation to alternative interventions than systematically assigned group of patients (75).
post-treatment. Checking for publication bias revealed the Earlier studies tended to show negligible differences existence of "file drawer" studies favouring PDT, which abol- between PDT and CBT, but the trials were too small and ished the inferiority.
Effect sizes at follow-up relative to other treatments are A health economics study reported that the end of treat- insignificant overall (31,94,96), but PDT performed signifi- ment cost-effectiveness of CBT and PDT compared to wait- cantly worse against CBT (31) and in geriatric studies (31).
list was uncertain and depended on societal willingness to PDT is comparable to alternative treatments at long-term pay (WTP): CBT proved cost-effective at WTP  e16,100 follow-up. It also increases the effect of antidepressant med- per responder and PDT at WTP  e27,290 (106).
ication (31,96).
There are no studies of PDT against inactive controls in generalized anxiety disorder, except a study of Internet-based PDT, which yielded no evidence of superiority to waitlist control on anxiety ratings (107). An early study of apoorly specified PDT showed it to be inferior to both anxiety On the whole, evidence supports the use of PDT in the management training and cognitive therapy at termination treatment of depression, although its effects compared to and short-term follow-up (108). A small study comparing placebo and other inactive control treatments are moderate PDT to supportive therapy failed to find superiority of PDT rather than large. There is evidence that the effects are main- for interpersonal problems (109). An RCT contrasting CBT tained in both the short and long term. PDT may be a pre- with PDT found the former to be superior on self-reported ferred alternative to pharmacotherapy and certainly adds to measures of anxiety, but this was not confirmed by indepen- the effectiveness of medication. If CBT is more effective dent observer ratings (110). At 12-month follow-up, signifi- than PDT, this difference is neither large nor reliable. How- cant differences favouring CBT remained on two of the ever, there are too few large-scale trials to fully establish measures (110).
Two small studies of panic disorder have been reported.
The dynamic therapies considered under the heading In one study, panic-focused PDT was clearly superior to "PDT" are probably quite similar in practice, but vary in the- applied relaxation (73% vs. 39% response) (111), specifically oretical orientation, content focus, and style of delivery for those with comorbid personality disorders (112). A simi- (supportive vs. confrontational), and no single type of PDT lar study contrasted this treatment with CBT and found no emerges as particularly efficacious. The literature on long- significant differences, although a larger sample with the term PDT, which is still in its infancy, suggests that this same response ratios (47% PDT vs. 72% CBT) would lead to approach may have value, perhaps particularly with more statistical significance (H50.52) (113).
complex and chronic cases of depression. There is a ques- There is no evidence that PDT is helpful for obsessive- tion over the issue of cost-effectiveness of these therapies.
compulsive disorder (114). The single study adding PDT to Both established and currently emerging Internet applica- pharmacotherapy reported no significant clinical effect tions of PDT are of particular interest, because of their from this supplemental treatment (115).
potential for efficient dissemination.
There is only one study of PDT as an approach to post- traumatic stress disorder (PTSD) (116), which shows a sig-nificant reduction of intrusion and avoidance compared to waitlist, to about the same extent as hypnotherapy and trau-ma desensitization. Systematic reviews found insufficient evidence in relation to PTSD to warrant comment (117-119), although strong theoretical and clinical arguments Notwithstanding the high lifetime prevalence of anxiety have been advanced for incorporating a psychodynamic disorders (97), few studies have examined the effectiveness approach into PTSD treatment programmes (120).
of PDT for these conditions.
PDT has been shown to be superior to enhanced waitlist for social anxiety and social phobia (98-102). The most recent study, with 207 PDT and 79 waitlist patients, yieldedlarge differences in remission rates (26% vs. 9%) (100). A Meta-analyses have tended to combine different anxiety smaller study showed that adding group PDT to medication disorders when providing effect sizes (31,121). PDT is re- (clonazepam) reduced social anxiety (103) and immature ported to be significantly more effective than inactive control defence styles (104).
conditions with a medium effect size, and to be overall insig- Whilst short-term PDT outperformed applied relaxation, nificantly different when compared with alternative treat- it was equivalent or inferior to prolonged exposure in two ments. However, substantial heterogeneity is reported in small, early studies (98,99). More recent trials contrasting both primary and secondary outcomes. These conclusions PDT with CBT found small between-group differences differ from those of other reviewers (122,123) who compared in remission (100,102). Continuous measures of phobia PDT only with CBT and claimed definite superiority for the favoured CBT at termination. Between 6-month and 2-year latter. This claim, however, has been questioned (121) and follow-up, the differences between the two treatments dis- significant errors may indeed have crept into one of the appeared (105).
above meta-analyses (122).
World Psychiatry 14:2 - June 2015 than routine treatment (21%) and achieved outcomes com-parable to family therapy (41%) and cognitive analytic thera- The effectiveness of PDT for anxiety is crucial in the debate py (32%) (131).
between those who argue for specific treatment approaches, In a recent, exceptionally high-quality study (Anorexia as in CBT, versus those who support a generic approach Nervosa Treatment of OutPatients, ANTOP) (132,133), focal seeking to identify similar unconscious content across diag- dynamic psychotherapy was contrasted with enhanced CBT nostic groups.
and treatment as usual, which incorporated the same intensi- In relation to social anxiety and perhaps generalized anx- ty of psychotherapy, offered by community experts. Weight iety disorder and panic disorder, promising emerging evi- gains were comparable across the three groups over 12 dence supports the argument for a generic approach. The months. With respect to global outcome measures, patients case is weakened, however, by the absence of evidence for allocated to PDT had higher recovery rates than the control PTSD and the evidence of absence of effect for obsessive- group; this was the first study to show superiority to CBT.
compulsive disorder. In general, the methodological weak- Patients in the control group more frequently required inpa- nesses of earlier studies call meta-analytic findings into tient treatment (41%) than those receiving PDT (23%) or CBT (35%). Although full syndrome anorexia nervosa per- Overall, there is considerable potential for further sound sisted in 21% of PDT patients (versus 28% of controls), the research aiming to identify the anxiety conditions for which findings, in association with other studies (134), suggest that PDT may be particularly helpful.
a focus on intra- and interpersonal factors is beneficial forindividuals with this disorder (135).
PDT in the treatment of anorexia nervosa in 12-19-year olds was found to be comparable to family-based treat-ment after 12-18 months of implementation in terms of A small study showed self-psychology oriented PDT to be achieving a target weight, but slightly inferior in terms of superior to nutritional counselling in treating a combination change in body mass index and more frequent hospitaliza- of anorexia and bulimia nervosa. The comparison with an tion (136,137). In an independent study of PDT versus active treatment in the same study (cognitive orientation family-based therapy, age appeared to be a significant therapy) favoured PDT, particularly for bulimia nervosa moderator, with older patients benefitting more from indi- (124). By contrast, two studies focusing on bulimia nervosa vidual therapy and younger patients from family-based found both PDT and CBT to be effective in reducing eating approaches in both short-term (138) and long-term fol- disorder symptoms, but CBT was slightly superior on global low-up (139). A definitive study with larger samples found measures of clinical outcome, self-rated psychopathology that, even for older adolescents, family-based treatment and some indicators of social adjustment (125,126).
achieved higher rates of remission and larger treatment A 16-week course of group psychodynamic psychothera- effects than individual treatment (140).
py for binge eating disorder was superior to treatment asusual on all measures, and mostly equivalent to group CBTin reducing binge eating and overall improvement (79% PDT vs. 73% CBT) (127). PDT resulted in lower depressionand more improvement in self-esteem, but greater suscepti- There is strong evidence (two independent RCTs, one of bility to hunger. There was some indication that patients which is large) that PDT can contribute to recovery from with higher attachment anxiety benefitted more from PDT.
anorexia nervosa. This is underscored by the fact that treat- A recent report of an RCT of 70 patients with bulimia ner- ment as usual in the ANTOP trial included psychotherapy, vosa, contrasting 2 years of once-weekly PDT with 20 ses- which, given the location of the study (Germany), was most sions of CBT over 5 months, found CBT to be more effective likely to have been non-manualized PDT.
in both the short (5 months) and long (2 years) term (128).
While available studies are small and conflicting, there is Both treatments were effective in reducing eating disorder sufficient uncertainty about the relevance of PDT for bulim- symptoms and general psychopathology. On the face of it, ia nervosa to warrant further research in which the imple- this finding might be considered to have appropriately chal- mentation of the therapy is more appropriately symptom- lenged the value of PDT, except that, strangely, this manual- ization of PDT precluded addressing bingeing and purgingunless the topic was volunteered by the patient (129). Thefindings drew attention to the importance of adapting PDT to the patient's presenting problems (130).
An RCT comparing focal PDT with family therapy, cogni- A number of studies have examined the usefulness of tive analytic therapy and routine treatment of anorexia ner- interpersonally oriented PDT for individuals presenting with vosa found that PDT achieved more improvement (52%) a range of pain symptoms.
A relatively large study of irritable bowel syndrome pa- significant differences between groups for follow-up hospi- tients, randomized to usual (medical) care or PDT (plus usual tal costs (151).
care), reported substantial changes in somatic symptoms,abdominal pain and bowel dysfunction at 3 and 15 months inthe PDT group (141). A 12-week trial found that women pre- senting with irritable bowel syndrome benefitted more fromPDT than from active listening in terms of self- and doctor- No meta-analyses have been reported recently. A limited rated symptoms (142). Those in the control group who ac- review identified only 13 RCTs and a moderate effect size cepted psychotherapy after the end of treatment improved, for somatic symptoms (d520.59; 95% CI: 20.78 to 20.40), and those who declined relapsed.
but the random effects model failed to reach significance A further study with people with the same clinical prob- (152). The effects are clearer for psychiatric symptoms and lems contrasted eight sessions of PDT with pharmacological social adjustment than somatic symptoms.
treatment (paroxetine) and treatment as usual (143). Bothactive treatments reduced physical distress but neither im-proved pain ratings. Psychotherapy reduced health care costs during the follow-up year. Patients with a history ofsexual abuse particularly benefitted from PDT, but those The evidence base for PDT in somatoform disorders com- with depression did better with paroxetine treatment.
pared to control treatments is quite robust. Although there A comparison of PDT with supportive psychotherapy in are no adequate meta-analytic summaries, this narrative patients with dyspepsia reported that at 1 year 54% felt review clearly reveals that an interpersonal form of dynamic physically much better with the former treatment, com- therapy has substantial and relatively long-term effects, with pared to 28% of those receiving the latter (144). The physi- medium effect sizes compared to enhanced treatment as cal improvements were in line with improvements in usual, and that PDT may be able to reduce long-term health psychological symptoms in the PDT group. These findings care costs for somatic disorders.
were replicated in a small Iranian RCT, indicating cultural Interestingly, there appear to have been no comparisons with active symptom-focused psychosocial treatments such A well-powered trial in patients with chronic pain symp- as CBT. Yet, a comparison may be relatively easy, since in toms, randomized to PDT or enhanced medical care, yielded this context PDT is mostly offered as a particularly brief medium between-group effects (d50.42) for physical quality intervention (8-10 sessions).
of life at 9-month follow-up (146). An earlier study with a The overall impression is that PDT may be more effective smaller sample of patients with somatoform pain disorder when somatoform disorders are associated with adverse and a much longer (33 sessions) treatment also yielded sig- social histories rather than manifest psychiatric problems.
nificant pain reductions, in addition to improvements insomatization, mood and social adjustment (147).
An evaluation of 25 sessions of PDT compared to four consultations over 6 months for patients with fibromyalgiafound no evidence of superiority of PDT for symptoms spe- RCTs suggest that the value of PDT in the treatment of cific to this disorder or general psychiatric problems (148).
drug dependence is moderated by the substance involved.
However, the training offered to the therapists was brief An early study of methadone-maintained opiate dependence (4 hours) and focused on insight rather than interpersonal found drug counselling plus either supportive-expressive emotional awareness, which has been found to be more rel- PDT or CBT to be beneficial relative to drug counselling evant (149).
alone, but there were no differences between the two psy- An imaginative study randomized general practitioners chotherapies (153-155). Patients with psychiatric morbidity to be trained to work jointly with psychodynamic psycho- benefitted most from the psychotherapies (156). A replica- therapists to deliver 10 weekly group therapy sessions tion study of methadone users with psychiatric morbidity in addition to the diagnosis and psychological management contrasted only PDT with counselling and observed a reduc- of medically unexplained symptoms (150). This large trial tion of cocaine-positive but not opiate-positive urine sam- found significant small to medium health benefits over ples during the treatment period (157). Importantly, this enhanced medical care from this psychodynamic group study demonstrated better maintenance of abstinence at 6 months, lower-dose methadone use and a significant reduc- A large quasi-experimental study compared pre- and tion in psychiatric morbidity.
post-treatment health care costs for 890 patients treated A study of cocaine dependence, contrasting CBT, PDT with brief PDT for a broad range of somatic and psychiatric and individual drug counselling based on the 12-step philos- disorders with those of a control group (N5192) who were ophy (all incorporating group drug counselling) with group referred but never treated, and found an average cost reduc- drug counselling alone, found individual drug counselling tion per treated case of $12,628 over 3 follow-up years, with to be most efficacious (158). Neither CBT nor PDT added World Psychiatry 14:2 - June 2015 benefit to group drug counselling, and they did not differ is limited even for CBT. The available evidence for PDT sug- from each other in terms of effectiveness. Thirty-eight per- gests some possible immediate benefit from dynamic ap- cent of individual drug counselling patients compared to proaches, but benefits are not sustained in the longer term.
18% of PDT patients maintained 3 months of consecutiveabstinence. However, individual drug counselling did notreduce psychiatric symptoms, unemployment, or medico- PERSONALITY DISORDERS legal, social, alcohol or interpersonal problems to a greaterextent than the other treatments (159).
A relatively wide range of dynamic therapies have been evaluated for a number of personality disorders, against bothactive and inactive control treatments. A number of small tri- als report intensive, relatively brief (25-40 sessions) PDT tobe superior to minimal contact (166), waitlist (167,168) and It is unclear whether PDT should be recommended to treatment as usual (169-172). Some studies demonstrated supplement the treatment of opiate-dependent individuals.
the value of longer-term treatments for specific diagnoses, Individual drug counselling clearly has benefit and, since for example, borderline personality disorder (173,174).
contingency management has become a preferred treatment Brief therapies do less well against active controls. In for dependency problems (20,40), the role of PDT in the mixed personality disorder populations, manualized PDT treatment of drug dependence is currently doubtful.
was not superior to supportive psychotherapy (175), adap-tive psychotherapy (167) or non-manualized community-delivered PDT (176). In a comparison of non-manualized PDT with CBT, the latter was more efficacious over a20-session treatment and follow-up for avoidant personality A Cochrane review of individual PDT for schizophrenia disorder (168). In contrast, a trial of manualized PDT versus and severe mental illness, including four randomized trials CBT for cluster C personality disorder patients reported no with 528 participants, found that patients who had received significant differences and a somewhat more rapid reduction PDT used less medication, were no more or less likely to be of symptom distress in the PDT group (177). A further com- rehospitalized, but were less likely to be discharged (160).
parison between PDT, CBT and brief relational therapy There was no clear evidence of any positive effect of PDT (which focuses on ruptures in the therapeutic alliance) found and adverse effects were not considered. Another meta- that the latter two treatments were associated with a higher analytic review (161), which identified 37 studies with 2,642 percentage of clinically significant and reliable change in the patients, incorporated many studies from the 1950s to the treatment of cluster C personality disorder, although the dif- 1970s, when treatment pathways and practices were quite ferences were not significant (178).
different, which makes the pooled estimates impossible to There have been larger trials with active treatment com- parisons focused on borderline personality disorder. Trans- In a partial RCT, the Danish National Schizophrenia ference-focused psychotherapy was shown to be superior to Project (162), patients with first episode psychosis received supportive psychotherapy and dialectical behaviour thera- one of three treatment packages: one including PDT, the py on some symptom measures (improving irritability, second multi-family treatment, and the third treatment as anger and assault and impulsivity) (179) as well as a num- usual. Only a small subgroup of patients was randomized.
ber of attachment-related measures (180). Similarly, When controlled for drug and alcohol use, the 1-year com- mentalization-based treatment was shown to be superior parison revealed benefit from PDT (162). A further analysis to structured clinical management of equal intensity (181), after 2 years contrasted treatment as usual (N5150) with particularly for patients with more than two personality PDT (N5119) (only 72 patients had been randomly allocat- disorder diagnoses (182). Mentalization-based treatment ed). Patients receiving PDT had higher Global Assessment was also found to be superior to supportive group therapy, of Functioning scores (medium effect size) (163). Benefits but only in terms of global assessment of functioning, at were no longer evident at 5-year follow-up (164).
termination (183) and at 18-month follow-up (184). How- A pilot study of psychodynamic art therapy vs. treatment ever, an RCT comparing transference-focused psychother- as usual with a small sample found a post-treatment reduc- apy and CBT (schema-focused therapy) found CBT to be tion in positive psychotic symptoms, which dissipated 6 more effective, particularly because early dropout rates weeks later (165).
were higher for the former treatment (185). In this context,it is noteworthy that the introduction of mentalization-based treatment to a specialist unit for borderline personal- ity disorder was historically associated with a substantialreduction of dropouts (from 15% to 2%) (186).
There is increasing optimism about the value of psycholog- While the inclusion of general psychiatric management ical therapy for psychosis, although the supporting evidence in a review of PDT may perhaps be controversial, this "dynamically informed" intervention, manualized by two while mentalization-based treatment is deemed probably ef- psychodynamic practitioners (187), owes much to dynamic ficacious. In fact, a number of the comparator treatments techniques and conceptualization of borderline personality considered above also have strong claims to being empirical- disorder. It has been shown to be comparable to dialectical ly supported, notably relational psychotherapy for general behaviour therapy at termination (188) and 2-year follow- personality disorder (193), manualized dynamic supportive therapy (194) and brief adaptive psychotherapy (195).
A review of the treatment of personality disorders (196) summarizes the characteristics required for an effective treat- ment as structured, focused on developing agency, integrativeof feelings and actions, active and validating, and incorporat- There are few meta-analyses specific to PDT for personal- ing supervision. Most dynamic therapies will incorporate ity disorders, although a number of the meta-analyses focus- these features. Their relative efficacy is thus hardly surprising.
ing on long-term psychotherapy capture many if not all ofthe relevant studies (190,191).
One meta-analysis of controlled and uncontrolled studies for patients with comorbid depression reported large pre-post effect sizes (d51-1.27) and superiority to waitlist, but What can be concluded about the efficacy of PDT? In- no significant differences in efficacy compared to other triguingly, different reviews of the same literature appear treatments (63). The most comprehensive meta-analysis sometimes to reach dramatically different conclusions (190, reported medium effect sizes compared to inactive controls 191,197-201). There is a clear need for authors to declare (31). Active treatment comparisons yield insignificant but interests, since the conclusions of reviews often appear to negative effect sizes (g520.15, 95% CI: 20.3 to 0.1) and no reflect the authors' theoretical orientation, just as the out- significant difference at follow-up.
comes of individual studies appear to be highly correlated Breaking down outcomes to symptomatology, global func- with the first author's affiliation (202). This tendency is tioning, interpersonal problems, depression and suicidality regrettable, because the lack of balance and the determina- also revealed no significant differences between PDT and tion to use statistics primarily for support leads to entrenched other therapies on any of these dimensions, but medium traditions and conflicts with the need to innovate through effect sizes in relation to control treatments. A marginally sig- the process of collaboration that is so characteristic of discov- nificant association between the number of sessions and ery science.
effect size is reported.
The extension of the evidence-based movement to psycho- However, it would be wrong to argue that complex disor- therapy, which we strongly support, may have reinforced a ders always require complex and long-term PDT interven- conservatism by raising the bar for accepting innovative ap- tions. Patients with chronic mental disorders (average 5-year proaches. Could CBT be discovered and disseminated now chronicity), who were frequent utilizers of mental health under the empirically supported therapies paradigm (203)? services, were randomized to treatment as usual or very brief Complex combinations of techniques have been packaged as (8-session) PDT (192). Six months post-treatment there were empirically supported therapies. Increasingly, developers significant benefits in terms of general psychiatric distress, have prioritized the implementation of packages without social functioning, quality of life, and resource utilization in regard to the unique value of each component. These treat- terms of outpatient attendance, general practitioner contacts, ment packages evolve in relation to what many now consider nurse contacts and medication. The cost of psychotherapy a less-than-adequate system of diagnostic classification (204- was recouped through reductions in resource use. The study 206). Transdiagnostic considerations will ultimately out- underscores the absence of a simple linear relationship be- weigh syndrome-specific treatment recommendations.
tween the length of a dynamic treatment and the severity of Given all this, is it possible to make meaningful recom- mendations about PDT based on the evidence? The follow-ing suggestions seem to be well grounded in data:  Treatment approaches generated from PDT principles appear to benefit individuals who present with depres- The evidence concerning personality disorders is rela- sion, some forms of anxiety, eating disorders and so- tively robust in highlighting the superiority of PDT over matic problems.
controls across key clinical variables including suicidality,  Implementations of the same principles in long-term treat- global and interpersonal functioning, as well as comorbid ments (1 year and longer) appear to benefit individuals with complex disorders where the severity manifests as a The American Psychological Association (Division 12) combination of syndromal and spectral-level problems (a has designated transference-focused psychotherapy a well- generally high level of vulnerability to psychopathology) established treatment for borderline personality disorder, World Psychiatry 14:2 - June 2015  There is little evidence to suggest that PDT is superior to Gardner and Dr. A. Higgitt for assistance with the litera- other therapeutic approaches. Its implementation in ture review and drafting the manuscript, and Dr. P. Luyten most instances will depend on the availability of appro- for helpful discussions.
priately trained personnel and their willingness to ac-quire the specific techniques that have been shown to be efficacious to a level of competence on a par with per-sonnel delivering treatments in RCTs.
1. Weisz JR, Kazdin AE (eds). Evidence-based psychotherapies for  The speed of recovery and cost-effectiveness of interven- children and adolescents, 2nd ed. New York: Guilford Press, 2010.
tions is a crucial parameter, since there is little evidence 2. Clark DM. Implementing NICE guidelines for the psychological that in the long term major differences exist between thera- treatment of depression and anxiety disorders: the IAPT experi- pies in terms of recovery or remission. Any apparent superi- ence. Int Rev Psychiatry 2011;23:318-27.
ority of long-term PDT is attributable to the prolonged con- 3. Layard R, Clark D. Thrive: the power of evidence-based psycho- logical therapies. London: Allen Lane, 2014.
tact between patient and therapist.
4. Holmes EA, Craske MG, Graybiel AM. Psychological treat- ments: a call for mental-health science. Nature 2014;511:287-9.
Looking towards the future, the modularization of inter- 5. Beck JG, Castonguay LG, Chronis-Tuscano A et al. Principles ventions and their combination to meet the needs of individ- for training in evidence-based psychology: recommendations for ual patients is the highest priority. Currently, there are very the graduate curricula in clinical psychology. Clin Psychol SciPract 2014;21:410-24.
few systematic, empirically tested protocols for combining 6. Stratton P. Formulating research questions that are relevant to treatments in either pharmacotherapy or psychotherapy. Yet, psychotherapy. Ment Health Learning Disabilities Res Practice the reality is that most patients receive empirically untested combinations. In the newly established self-report system of 7. Cartwright N, Munro E. The limitations of randomized con- the U.K.'s Children and Young People's Improving Access to trolled trials in predicting effectiveness. J Eval Clin Pract 2010;16:260-6.
Psychological Therapies programme (CYP IAPT), the treat- 8. Borduin CM, Mann BJ, Cone LT et al. Multisystemic treatment ment most commonly offered – almost twice as often as any- of serious juvenile offenders: long-term prevention of criminality thing else – is "other"; that is, not CBT, family therapy, PDT and violence. J Consult Clin Psychol 1995;63:569-78.
or counselling.
9. Henggeler SW, Melton GB, Smith LA. Family preservation using In developing new therapies, researchers have to aim to multisystemic therapy: an effective alternative to incarcerating seri-ous juvenile offenders. J Consult Clin Psychol 1992;60:953-61.
innovate in the direction of directly addressing the deficits 10. Henggeler SW, Melton GB, Brondino MJ et al. Multisystemic patients with mental disorder present with. The alignment therapy with violent and chronic juvenile offenders and their of PDT with such deficits is the most important priority. We families: the role of treatment fidelity in successful dissemina- may well be concerned that current PDT approaches are tion. J Consult Clin Psychol 1997;65:821-33.
too deeply rooted in the technical preferences of developers 11. Henggeler SW, Pickrel SG, Brondino MJ. Multisystemic treat- ment of substance-abusing and dependent delinquents: out- (supportive vs. expressive, relational vs. ego-oriented, self- comes, treatment fidelity, and transportability. Ment Health Serv psychological vs. conflict-focused, etc.). This is the language Res 1999;1:171-84.
of professionals rather than patients. Each approach may 12. Henggeler SW, Halliday-Boykins CA, Cunningham PB et al. Juve- have meaningful components in relation to particular indi- nile drug court: enhancing outcomes by integrating evidence- viduals, but how is a therapist to know which approach to based treatments. J Consult Clin Psychol 2006;74:42-54.
13. Ogden T, Hagen KA. Multisystemic treatment of serious behav- apply to whom? The evidence certainly does not speak to iour problems in youth: sustainability of effectiveness two years such a choice.
after intake. Child Adolesc Ment Health 2006;11:142-9.
If the field is to advance, we have to do more than talk 14. Rowland MD, Halliday-Boykins CA, Henggeler SW et al. A ran- about the global effectiveness of a heterogeneous category of domized trial of multisystemic therapy with Hawaii's Felix Class approaches, such as PDT, in relation to a heterogeneous Youths. J Emot Behav Disord 2005;13:13-23.
15. Timmons-Mitchell J, Bender MB, Kishna MA et al. An indepen- group of patients, such as those who experience depression.
dent effectiveness trial of multisystemic therapy with juvenile There have been some attempts to match particular presenta- justice youth. J Clin Child Adolesc Psychol 2006;35:227-36.
tions to specific PDT techniques (e.g., work on introjective 16. Borduin CM, Schaeffer CM, Heiblum N. A randomized clinical vs. anaclitic depression) (209-211). However, there is consid- trial of multisystemic therapy with juvenile sexual offenders: erably more to be achieved by "playful" experimentation, effects on youth social ecology and criminal activity. J ConsultClin Psychol 2009;77:26-37.
probably driven by advances in bioscience and computation- 17. Schoenwald SK, Chapman JE, Sheidow AJ et al. Long-term al psychiatry.
youth criminal outcomes in MST transport: the impact of thera-pist adherence and organizational climate and structure. J ClinChild Adolesc Psychol 2009;38:91-105.
18. Butler S, Baruch G, Hickey N et al. A randomized controlled tri- al of multisystemic therapy and a statutory therapeutic interven-tion for young offenders. J Am Acad Child Adolesc Psychiatry The author acknowledges funding from the National Institute for Health Research (Senior Investigator Award 19. National Institute for Health and Clinical Excellence. Antisocial NF-51-0514-10157). He wishes to thank Dr. E. Allison, T.
personality disorder: treatment, management and prevention.
London: The British Psychological Society and the Royal Col- dynamic approaches to psychopathology. New York: Guilford (in lege of Psychiatrists, 2010.
20. Fonagy P, Cottrell D, Phillips J et al. What works for whom? A 40. Roth A, Fonagy P. What works for whom? A critical review of critical review of treatments for children and adolescents, 2nd psychotherapy research, 2nd ed. New York: Guilford Press, ed. New York: Guilford Press, 2014.
21. Kazdin AE. Understanding how and why psychotherapy leads 41. Carrington CH. A comparison of cognitive and analytically ori- to change. Psychother Res 2009;19:418-28.
ented brief treatment approaches to depression in black women.
22. Mill JS. On the definition of political economy and on the meth- Doctoral dissertation, University of Maryland, 1979.
od of philosophical investigation in that science. Reprinted in 42. Maina G, Forner F, Bogetto F. Randomized controlled trial Collected Works of John Stuart Mill, Vol. IV. Toronto: Universi- comparing brief dynamic and supportive therapy with waiting ty of Toronto Press, 1836/1967.
list condition in minor depressive disorders. Psychother Psycho- 23. Mellor-Clark J, Cross S, Macdonald J et al. Leading horses to som 2005;74:43-50.
water: lessons from a decade of helping psychological therapy 43. Lopez D, Cuevas P, Gomez A et al. Psicoterapia focalizada en la services use routine outcome measurement to improve practice.
transferencia para el trastorno lımite de la personalidad. Un Adm Policy Ment Health (in press).
estudio con pacientes femeninas. Salud Ment 2004;27:44-54.
24. Fisher B, Wolmark N, Redmond C et al. Findings from NSABP 44. McLean PD, Hakstian AR. Clinical depression: comparative effica- Protocol No. B-04: comparison of radical mastectomy with al- cy of outpatient treatments. J Consult Clin Psychol 1979;47:818- ternative treatments. II. The clinical and biologic significance of medial-central breast cancers. Cancer 1981;48:1863-72.
45. Barber JP, Barrett MS, Gallop R et al. Short-term dynamic psy- 25. Huhn M, Tardy M, Spineli LM et al. Efficacy of pharmacothera- chotherapy versus pharmacotherapy for major depressive disor- py and psychotherapy for adult psychiatric disorders: a system- der: a randomized, placebo-controlled trial. J Clin Psychiatry atic overview of meta-analyses. JAMA Psychiatry 2014;71:706- 46. Zilcha-Mano S, Dinger U, McCarthy KS et al. Changes in well- 26. Correll CU, Carbon M. Efficacy of pharmacologic and psycho- being and quality of life in a randomized trial comparing dynam- therapeutic interventions in psychiatry: to talk or to prescribe: is ic psychotherapy and pharmacotherapy for major depressive that the question? JAMA Psychiatry 2014;71:624-6.
disorder. J Affect Disord 2014;152-154:538-42.
27. Hennekens CH, Demets D. The need for large-scale randomized 47. Vitriol VG, Ballesteros ST, Florenzano RU et al. Evaluation of evidence without undue emphasis on small trials, meta-analyses, an outpatient intervention for women with severe depression or subgroup analyses. JAMA 2009;302:2361-2.
and a history of childhood trauma. Psychiatr Serv 2009;60:936-42.
28. Barker LE, Luman ET, McCauley MM et al. Assessing equiva- 48. Simpson S, Corney R, Fitzgerald P et al. A randomized con- lence: an alternative to the use of difference tests for measuring trolled trial to evaluate the effectiveness and cost-effectiveness disparities in vaccination coverage. Am J Epidemiol 2002;156: of psychodynamic counselling for general practice patients with chronic depression. Psychol Med 2003;33:229-39.
29. Walker E, Nowacki AS. Understanding equivalence and nonin- 49. Cooper PJ, Murray L, Wilson A et al. Controlled trial of the feriority testing. J Gen Intern Med 2011;26:192-6.
short- and long-term effect of psychological treatment of post- 30. Cohen J. Statistical power analysis for the behavioral sciences, partum depression. I. Impact on maternal mood. Br J Psychia- 2nd ed. Hillsdale: Lawrence Erlbaum Associates, 1988.
try 2003;182:412-9.
31. Barber JP, Muran JC, McCarthy KS et al. Research on dynamic 50. Gibbons MB, Thompson SM, Scott K et al. Supportive-expres- therapies. In: Lambert M (ed). Bergin and Garfield's handbook of sive dynamic psychotherapy in the community mental health psychotherapy and behavior change. New York: Wiley, 2013:443- system: a pilot effectiveness trial for the treatment of depression.
32. Fonagy P, Target M. Psychodynamic treatments. In: Rutter M, 51. Bastos AG, Guimaraes LS, Trentini CM. The efficacy of long- Bishop D, Pine D et al (eds). Rutter's child and adolescent psy- term psychodynamic psychotherapy, fluoxetine and their combi- chiatry, 5th ed. Oxford: Blackwell, 2008:1079-91.
nation in the outpatient treatment of depression. Psychother Res 33. McCullough JP, Jr. Treatment for chronic depression using Cog- 2014; 21:1-13.
nitive Behavioral Analysis System of Psychotherapy (CBASP).
52. Wampold BE, Mondin GW, Moody M et al. A meta-analysis of J Clin Psychol 2003;59:833-46.
outcome studies comparing bona fide therapies: empirically, ‘All 34. Ryle A, Kerr IB. Introducing cognitive analytic therapy: princi- must have prizes'. Psychol Bull 1997;122:203-15.
ples and practice. Chichester: Wiley, 2002.
53. Beutel ME, Weissflog G, Leuteritz K et al. Efficacy of short-term 35. Weissman MM, Markowitz JC, Klerman GL. Clinician's quick psychodynamic psychotherapy (STPP) with depressed breast guide to interpersonal psychotherapy. New York: Oxford Universi- cancer patients: results of a randomized controlled multicenter ty Press, 2007.
trial. Ann Oncol 2014;25:378-84.
36. Safran JD. The relational turn, the therapeutic alliance, and psy- 54. Bressi C, Porcellana M, Marinaccio PM et al. Short-term psy- chotherapy research: strange bedfellows or postmodern mar- chodynamic psychotherapy versus treatment as usual for depres- riage? Contemporary Psychoanalysis 2003;39:449-75.
sive and anxiety disorders: a randomized clinical trial of efficacy.
37. Luborsky L. Principles of psychoanalytic psychotherapy: a manual J Nerv Ment Dis 2010;198:647-52.
for supportive-expressive (SE) treatment. New York: Basic Books, 55. Xie CL, Wang XD, Chen J et al. A systematic review and meta- analysis of cognitive behavioral and psychodynamic therapy for 38. Seybert C, Erhardt I, Levy R et al. Manualized treatments for depression in Parkinson's disease patients. Neurol Sci (in press).
psychodynamic psychotherapy research. In: Levy RA, Ablon JS, 56. de Jonghe F, Kool S, van Aalst G et al. Combining psychothera- Kaechele H (eds). Psychodynamic psychotherapy research: prac- py and antidepressants in the treatment of depression. J Affect tice based evidence and evidence based practice. New York: Humana Press, 2011:395-402.
57. Molenaar PJ, Dekker J, Van R et al. Does adding psychothera- 39. Leichsenring F, Kruse J, Rabung S. Efficacy of psychodynamic psy- py to pharmacotherapy improve social functioning in the chotherapy in specific mental disorders: an update. In: Luyten P, treatment of outpatient depression? Depress Anxiety 2007;24: Mayes L, Fonagy P et al (eds). Handbook of contemporary psycho- World Psychiatry 14:2 - June 2015 58. Burnand Y, Andreoli A, Kolatte E et al. Psychodynamic psycho- 77. Shapiro DA, Barkham M, Rees A et al. Effects of treatment dura- therapy and clomipramine in the treatment of major depression.
tion and severity of depression on the effectiveness of cognitive- Psychiatr Serv 2002;53:585-90.
behavioral and psychodynamic-interpersonal psychotherapy.
59. Dekker J, Molenaar PJ, Kool S et al. Dose-effect relations in J Consult Clin Psychol 1994;62:522-34.
time-limited combined psycho-pharmacological treatment for 78. Gallagher-Thompson D, Steffen AM. Comparative effects of depression. Psychol Med 2005;35:47-58.
cognitive-behavioral and brief psychodynamic psychotherapies 60. de Jonghe F, Hendrikson M, van Alst E et al. Psychotherapy for depressed family caregivers. J Consult Clin Psychol 1994;62: alone and combined with pharmacotherapy in the treatment of depression. Br J Psychiatry 2004;185:37-45.
79. Thompson LW, Gallagher D, Breckenridge JS. Comparative 61. de Maat S, Dekker J, Schoevers R et al. Short psychodynamic sup- effectiveness of psychotherapies for depressed elders. J Consult portive psychotherapy, antidepressants, and their combination in Clin Psychol 1987;55:385-90.
the treatment of major depression: a mega-analysis based on three 80. Gallagher DE, Thompson LW. Treatment of major depressive randomized clinical trials. Depress Anxiety 2008;25:565-74.
disorder in older adult outpatients with brief psychotherapies.
62. Kool S, Dekker J, Duijsens IJ et al. Efficacy of combined therapy Psychotherapy: Theory, Research and Practice 1982;19:482-90.
and pharmacotherapy for depressed patients with or without 81. LaPointe KA, Rimm DC. Cognitive, assertive, and insight-oriented personality disorders. Harv Rev Psychiatry 2003;11:133-41.
group therapies in the treatment of reactive depression in women.
63. Abbass A, Town J, Driessen E. The efficacy of short-term psy- Psychotherapy: Theory, Research and Practice 1980;17:312-21.
chodynamic psychotherapy for depressive disorders with co- 82. Thompson LW, Gallagher DE. Efficacy of psychotherapy in the morbid personality disorder. Psychiatry 2011;74:58-71.
treatment of late-life depression. Adv Behav Res Ther 1984;6: 64. Nemeroff CB, Heim CM, Thase ME et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic 83. Knekt P, Lindfors O, Laaksonen MA et al. Effectiveness of forms of major depression and childhood trauma. Proc Natl Acad short-term and long-term psychotherapy on work ability and Sci USA 2003;100:14293-6.
functional capacity – a randomized clinical trial on depressive 65. Maina G, Rosso G, Bogetto F. Brief dynamic therapy combined and anxiety disorders. J Affect Disord 2008;107:95-106.
with pharmacotherapy in the treatment of major depressive dis- 84. Johansson R, Ekbladh S, Hebert A et al. Psychodynamic guided order: long-term results. J Affect Disord 2009;114:200-7.
self-help for adult depression through the internet: a randomised 66. Rosso G, Martini B, Maina G. Brief dynamic therapy and de- controlled trial. PLoS One 2012;7:e38021.
pression severity: a single-blind, randomized study. J Affect Dis- 85. Johansson R, Bjorklund M, Hornborg C et al. Affect-focused ord 2013;147:101-6.
psychodynamic psychotherapy for depression and anxiety 67. Salminen JK, Karlsson H, Hietala J et al. Short-term psychody- through the Internet: a randomized controlled trial. Peer J 2013; namic psychotherapy and fluoxetine in major depressive disor- der: a randomized comparative study. Psychother Psychosom 86. Knekt P, Laaksonen MA, Raitasalo R et al. Changes in lifestyle for psychiatric patients three years after the start of short- and 68. Bloch M, Meiboom H, Lorberblatt M et al. The effect of sertraline long-term psychodynamic psychotherapy and solution-focused add-on to brief dynamic psychotherapy for the treatment of post- therapy. Eur Psychiatry 2010;25:1-7.
partum depression: a randomized, double-blind, placebo-control- 87. Knekt P, Lindfors O, Laaksonen MA. Review: long term psy- led study. J Clin Psychiatry 2012;73:235-41.
chodynamic psychotherapy improves outcomes in people with 69. Raue PJ, Schulberg HC, Heo M et al. Patients' depression treat- complex mental disorders. Evid Based Ment Health 2009;12:56.
ment preferences and initiation, adherence, and outcome: a ran- 88. Knekt P, Lindfors O, Harkanen T et al. Randomized trial on the domized primary care study. Psychiatr Serv 2009;60:337-43.
effectiveness of long- and short-term psychodynamic psycho- 70. Spielmans GI, Berman MI, Usitalo AN. Psychotherapy versus therapy and solution-focused therapy on psychiatric symptoms second-generation antidepressants in the treatment of depres- during a 3-year follow-up. Psychol Med 2008;38:689-703.
sion: a meta-analysis. J Nerv Ment Dis 2011;199:142-9.
89. Knekt P, Lindfors O, Laaksonen MA et al. Quasi-experimental 71. Driessen E, Van HL, Schoevers RA et al. Cognitive behavioral study on the effectiveness of psychoanalysis, long-term and therapy versus short psychodynamic supportive psychotherapy short-term psychotherapy on psychiatric symptoms, work ability in the outpatient treatment of depression: a randomized con- and functional capacity during a 5-year follow-up. J Affect Dis- trolled trial. BMC Psychiatry 2007;7:58.
ord 2011;132:37-47.
72. Driessen E, Van HL, Don FJ et al. The efficacy of cognitive- 90. Huber D, Henrich G, Clarkin J et al. Psychoanalytic versus psy- behavioral therapy and psychodynamic therapy in the outpa- chodynamic therapy for depression: a three-year follow-up tient treatment of major depression: a randomized clinical trial.
study. Psychiatry 2013;76:132-49.
Am J Psychiatry 2013;170:1041-50.
91. Huber D, Zimmermann J, Henrich G et al. Comparison of 73. Driessen E, Van Henricus L, Peen J et al. Therapist-rated out- cognitive-behaviour therapy with psychoanalytic and psychody- comes in a randomized clinical trial comparing cognitive behav- namic therapy for depressed patients – a three-year follow-up ioral therapy and psychodynamic therapy for major depression.
study. Z Psychosom Med Psychother 2012;58:299-316.
J Affect Disord 2015;170:112-8.
92. Fonagy P, Rost F, Carlyle J et al. Randomized controlled trial of 74. Watzke B, Ruddel H, Jurgensen R et al. Effectiveness of systematic long-term psychoanalytic psychotherapy for chronic "treatment- treatment selection for psychodynamic and cognitive-behavioural resistant/treatment-refractory" depression: the Tavistock Adult therapy: randomised controlled trial in routine mental healthcare.
Depression Study (TADS). Submitted for publication.
Br J Psychiatry 2010;197:96-105.
93. Abbass A, Driessen E. The efficacy of short-term psychodynamic 75. Watzke B, Ruddel H, Jurgensen R et al. Longer term outcome of psychotherapy for depression: a summary of recent findings.
cognitive-behavioural and psychodynamic psychotherapy in rou- Acta Psychiatr Scand 2010;121:398.
tine mental health care: randomised controlled trial. Behav Res 94. Driessen E, Cuijpers P, de Maat SCM et al. The efficacy of short- Ther 2012;50:580-7.
term psychodynamic psychotherapy for depression: a meta- 76. Barkham M, Rees A, Shapiro DA et al. Outcomes of time- analysis. Clin Psychol Rev 2010;30:25-36.
limited psychotherapy in applied settings: replicating the Second 95. Barth J, Munder T, Gerger H et al. Comparative efficacy of seven Sheffield Psychotherapy Project. J Consult Clin Psychol 1996; psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Med 2013;10:e1001454.
96. Cuijpers P, van Straten A, Andersson G et al. Psychotherapy for 115. Maina G, Rosso G, Rigardetto S et al. No effect of adding brief depression in adults: a meta-analysis of comparative outcome dynamic therapy to pharmacotherapy in the treatment of obsessive- studies. J Consult Clin Psychol 2008;76:909-22.
compulsive disorder with concurrent major depression. Psychother 97. Somers JM, Goldner EM, Waraich P et al. Prevalence and inci- dence studies of anxiety disorders: a systematic review of the lit- 116. Brom D, Kleber RJ, Defares PB. Brief psychotherapy for post- erature. Can J Psychiatry 2006;51:100-13.
traumatic stress disorders. J Consult Clin Psychol 1989;57: 98. Alstrom JE, Nordlund CL, Persson G et al. Effects of four treat- ment methods on agoraphobic women not suitable for insight- 117. Gillies D, Taylor F, Gray C et al. Psychological therapies for the oriented psychotherapy. Acta Psychiatr Scand 1984;70:1-17.
treatment of post-traumatic stress disorder in children and ado- 99. Alstrom JE, Nordlund CL, Persson G et al. Effects of four treat- lescents. Evid Based Child Health 2013;8:1004-116.
ment methods on social phobic patients not suitable for insight- 118. Ponniah K, Hollon SD. Empirically supported psychological oriented psychotherapy. Acta Psychiatr Scand 1984;70:97-110.
treatments for adult acute stress disorder and posttraumatic 100. Leichsenring F, Salzer S, Beutel ME et al. Psychodynamic thera- stress disorder: a review. Depress Anxiety 2009;26:1086-109.
py and cognitive-behavioral therapy in social anxiety disorder: a 119. Gerger H, Munder T, Gemperli A et al. Integrating fragmented multicenter randomized controlled trial. Am J Psychiatry 2013; evidence by network meta-analysis: relative effectiveness of psy- chological interventions for adults with post-traumatic stress 101. Knijnik DZ, Kapczinski F, Chachamovich E et al. Psychody- disorder. Psychol Med 2014;44:3151-64.
namic group treatment for generalized social phobia. Rev Bras 120. Schottenbauer MA, Glass CR, Arnkoff DB et al. Contributions of psychodynamic approaches to treatment of PTSD and trau- 102. Bogels SM, Wijts P, Oort FJ et al. Psychodynamic psychotherapy ma: a review of the empirical treatment and psychopathology lit- versus cognitive behavior therapy for social anxiety disorder: an erature. Psychiatry 2008;71:13-34.
efficacy and partial effectiveness trial. Depress Anxiety 2014;31: 121. Keefe JR, McCarthy KS, Dinger U et al. A meta-analytic review of psychodynamic therapies for anxiety disorders. Clin Psychol 103. Knijnik DZ, Blanco C, Salum GA et al. A pilot study of clonaze- Rev 2014;34:309-23.
pam versus psychodynamic group therapy plus clonazepam in 122. Tolin DF. Is cognitive-behavioral therapy more effective than the treatment of generalized social anxiety disorder. Eur Psychi- other therapies? A meta-analytic review. Clin Psychol Rev 2010; 104. Knijnik DZ, Salum GA, Jr., Blanco C et al. Defense style changes 123. Tolin DF. Beating a dead dodo bird: looking at signal vs. noise with the addition of psychodynamic group therapy to clonazepam in cognitive-behavioral therapy for anxiety disorders. Clin Psy- in social anxiety disorder. J Nerv Ment Dis 2009;197:547-51.
chol Sci Pract 2014;21:351-62.
105. Leichsenring F, Salzer S, Beutel ME et al. Long-term outcome of 124. Bachar E, Latzer Y, Kreitler S et al. Empirical comparison of psychodynamic therapy and cognitive-behavioral therapy in two psychological therapies. Self psychology and cognitive ori- social anxiety disorder. Am J Psychiatry 2014;171:1074-82.
entation in the treatment of anorexia and bulimia. J Psychother 106. Egger N, Konnopka A, Beutel ME et al. Short-term cost-effec- Pract Res 1999;8:115-28.
tiveness of psychodynamic therapy and cognitive-behavioral ther- 125. Fairburn CG, Kirk J, O'Connor M et al. A comparison of two apy in social anxiety disorder: results from the SOPHO-NET trial.
psychological treatments for bulimia nervosa. Behav Res Ther J Affect Disord 2015;180:21-8.
107. Andersson G, Paxling B, Roch-Norlund P et al. Internet-based 126. Garner DM, Rockert W, Davis R et al. Comparison of cognitive- psychodynamic versus cognitive behavioral guided self-help for behavioral and supportive-expressive therapy for bulimia nervo- generalized anxiety disorder: a randomized controlled trial. Psy- sa. Am J Psychiatry 1993;150:37-46.
chother Psychosom 2012;81:344-55.
127. Tasca GA, Ritchie K, Conrad G et al. Attachment scales predict 108. Durham RC, Murphy T, Allan T et al. Cognitive therapy, analytic outcome in a randomized controlled trial of two group therapies psychotherapy and anxiety management training for generalized for binge eating disorder: an aptitude by treatment interaction.
anxiety disorder. Br J Psychiatry 1994;165:315-23.
Psychother Res 2006;16:106-21.
109. Crits-Christoph P, Connolly Gibbons J, Schamberger M et al.
128. Poulsen S, Lunn S, Daniel SI et al. A randomized controlled trial Interpersonal problems and the outcome of interpersonally ori- of psychoanalytic psychotherapy or cognitive-behavioral thera- ented psychodynamic treatment of GAD. Psychotherapy: Theo- py for bulimia nervosa. Am J Psychiatry 2014;171:109-16.
ry, Research, Practice, Training 2005;42:211-24.
129. Lunn S, Poulsen S. Psychoanalytic psychotherapy for bulimia ner- 110. Leichsenring F, Salzer S, Jaeger U et al. Short-term psychody- vosa: a manualized approach. Psychoanal Psychother 2012;26: namic psychotherapy and cognitive-behavioral therapy in gener- alized anxiety disorder: a randomized, controlled trial. Am J Psy- 130. Poulsen S, Lunn S. Response to Tasca et al. Am J Psychiatry 111. Milrod B, Leon AC, Busch F et al. A randomized controlled clin- 131. Dare C, Eisler I, Russell G et al. Psychological therapies for ical trial of psychoanalytic psychotherapy for panic disorder.
adults with anorexia nervosa: randomised controlled trial of Am J Psychiatry 2007;164:265-72.
out-patient treatments. Br J Psychiatry 2001;178:216-21.
112. Milrod BL, Leon AC, Barber JP et al. Do comorbid personality 132. Wild B, Friederich HC, Gross G et al. The ANTOP study: focal disorders moderate panic-focused psychotherapy? An explor- psychodynamic psychotherapy, cognitive-behavioural therapy, atory examination of the American Psychiatric Association prac- and treatment-as-usual in outpatients with anorexia nervosa – a tice guideline. J Clin Psychiatry 2007;68:885-91.
randomized controlled trial. Trials 2009;10:23.
113. Beutel ME, Scheurich V, Knebel A et al. Implementing panic- 133. Zipfel S, Wild B, Gross G et al. Focal psychodynamic therapy, focused psychodynamic psychotherapy into clinical practice.
cognitive behaviour therapy, and optimised treatment as usual Can J Psychiatry 2013;58:326-34.
in outpatients with anorexia nervosa (ANTOP study): rando- 114. Ponniah K, Magiati I, Hollon SD. An update on the efficacy of mised controlled trial. Lancet 2014;383:127-37.
psychological therapies in the treatment of obsessive-compulsive 134. McIntosh VV, Jordan J, Carter FA et al. Three psychotherapies disorder in adults. J Obsessive Compuls Relat Disord 2013;2: for anorexia nervosa: a randomized, controlled trial. Am J Psy- World Psychiatry 14:2 - June 2015 135. Bulik CM. The challenges of treating anorexia nervosa. Lancet 156. Woody G, McLellan AT, Luborsky L et al. Psychiatric severity as a predictor of benefits from psychotherapy: The Veterans 136. Robin AL, Siegel PT, Moye A. Family versus individual therapy Administration - Penn Study. Am J Psychiatry 1984;141:1172-7.
for anorexia: impact on family conflict. Int J Eat Disord 1995;17: 157. Woody GE, McLellan AT, Luborsky L et al. Psychotherapy in community methadone programs: a validation study. Am J Psy- 137. Robin AL, Siegel PT, Moye AW et al. A controlled comparison of family versus individual therapy for adolescents with anorexia 158. Crits-Christoph P, Siqueland L, Blaine J et al. Psychosocial treat- nervosa. J Am Acad Child Adolesc Psychiatry 1999;38:1482-9.
ments for cocaine dependence: National Institute on Drug Abuse 138. Crisp AH, Norton KRW, Gowers SG et al. A controlled study of Collaborative Cocaine Treatment Study. Arch Gen Psychiatry the effect of therapies aimed at adolescent and family psychopa- thology in anorexia nervosa. Br J Psychiatry 1991;159:325-33.
159. Crits-Christoph P, Siqueland L, McCalmont E et al. Impact of 139. Eisler I, Dare C, Russell GF et al. Family and individual therapy psychosocial treatments on associated problems of cocaine- in anorexia nervosa. A 5-year follow-up. Arch Gen Psychiatry dependent patients. J Consult Clin Psychol 2001;69:825-30.
160. Malmberg L, Fenton M. Individual psychodynamic psychothera- 140. Lock J, Le Grange D, Agras S et al. Randomized clinical trial py and psychoanalysis for schizophrenia and severe mental ill- comparing family-based treatment with adolescent-focused indi- ness. Cochrane Database Syst Rev 2001:CD001360.
vidual therapy for adolescents with anorexia nervosa. Arch Gen 161. Gottdiener WH, Haslam N. The benefits of individual psychother- apy for people diagnosed with schizophrenia: a meta-analytic 141. Svedlund J, Sjodin I, Ottosson JO et al. Controlled study of psy- review. Ethical Hum Sci Services 2002;4:163-87.
chotherapy in irritable bowel syndrome. Lancet 1983;2:589-92.
162. Rosenbaum B, Valbak K, Harder S et al. The Danish National 142. Guthrie E, Creed F, Dawson D et al. A randomised controlled Schizophrenia Project: prospective, comparative longitudinal trial of psychotherapy in patients with refractory irritable bowel treatment study of first-episode psychosis. Br J Psychiatry 2005; syndrome. Br J Psychiatry 1993;163:315-21.
143. Creed F, Fernandes L, Guthrie E et al. The cost-effectiveness of 163. Rosenbaum B, Harder S, Knudsen P et al. Supportive psychody- psychotherapy and paroxetine for severe irritable bowel syn- namic psychotherapy versus treatment as usual for first-episode drome. Gastroenterology 2003;124:303-17.
psychosis: two-year outcome. Psychiatry 2012;75:331-41.
144. Hamilton J, Guthrie E, Creed F et al. A randomized controlled 164. Harder S, Koester A, Valbak K et al. Five-year follow-up of sup- trial of psychotherapy in patients with chronic functional dys- portive psychodynamic psychotherapy in first-episode psycho- pepsia. Gastroenterology 2000;119:661-9.
sis: long-term outcome in social functioning. Psychiatry 2014; 145. Faramarzi M, Azadfallah P, Book HE et al. A randomized con- trolled trial of brief psychoanalytic psychotherapy in patients 165. Montag C, Haase L, Seidel D et al. A pilot RCT of psychodynam- with functional dyspepsia. Asian J Psychiatry 2013;6:228-34.
ic group art therapy for patients in acute psychotic episodes: fea- 146. Sattel H, Lahmann C, Gundel H et al. Brief psychodynamic inter- sibility, impact on symptoms and mentalising capacity. PLoS personal psychotherapy for patients with multisomatoform disor- One 2014;9:e112348.
der: randomised controlled trial. Br J Psychiatry 2012;200:60-7.
166. Abbass A, Sheldon A, Gyra J et al. Intensive short-term dynamic 147. Monsen K, Monsen JT. Chronic pain and psychodynamic body psychotherapy for DSM-IV personality disorders: a randomized therapy: a controlled outcome study. Psychotherapy 2000;37: controlled trial. J Nerv Ment Dis 2008;196:211-6.
167. Winston A, Laikin M, Pollack J et al. Short-term psychotherapy 148. Scheidt CE, Waller E, Endorf K et al. Is brief psychodynamic of personality disorders. Am J Psychiatry 1994;151:190-4.
psychotherapy in primary fibromyalgia syndrome with concur- 168. Emmelkamp PM, Benner A, Kuipers A et al. Comparison of brief rent depression an effective treatment? A randomized con- dynamic and cognitive-behavioural therapies in avoidant per- trolled trial. Gen Hosp Psychiatry 2013;35:160-7.
sonality disorder. Br J Psychiatry 2006;189:60-4.
149. Luyten P, Abbass A. What is the evidence for specific factors in 169. Gregory RJ, DeLucia-Deranja E, Mogle JA. Dynamic deconstruc- the psychotherapeutic treatment of fibromyalgia? Comment on "Is tive psychotherapy versus optimized community care for border- brief psychodynamic psychotherapy in primary fibromyalgia syn- line personality disorder co-occurring with alcohol use disorders: a drome with concurrent depression an effective treatment? A ran- 30-month follow-up. J Nerv Ment Dis 2010;198:292-8.
domized controlled trial". Gen Hosp Psychiatry 2013;35:675-6.
170. Gregory RJ, Chlebowski S, Kang D et al. A controlled trial of 150. Schaefert R, Kaufmann C, Wild B et al. Specific collaborative psychodynamic psychotherapy for co-occurring borderline per- group intervention for patients with medically unexplained sonality disorder and alcohol use disorder. Psychotherapy 2008; symptoms in general practice: a cluster randomized controlled trial. Psychother Psychosom 2013;82:106-19.
171. Amianto F, Ferrero A, Piero A et al. Supervised team manage- 151. Abbass A, Kisely S, Rasic D et al. Long-term healthcare cost ment, with or without structured psychotherapy, in heavy users reduction with intensive short-term dynamic psychotherapy in a of a mental health service with borderline personality disorder: tertiary psychiatric service. J Psychiatr Res 2015;64:114-20.
a two-year follow-up preliminary randomized study. BMC Psy- 152. Abbass A, Kisely S, Kroenke K. Short-term psychodynamic psychotherapy for somatic disorders. Systematic review and 172. Reneses B, Galian M, Serrano R et al. A new time limited psy- meta-analysis of clinical trials. Psychother Psychosom 2009;78: chotherapy for BPD: preliminary results of a randomized and controlled trial. Actas Esp Psiquiatr 2013;41:139-48.
153. Woody GE, Luborsky L, McLellan AT et al. Psychotherapy for 173. Bateman AW, Fonagy P. Psychotherapy for severe personality opiate addicts. Does it help? Arch Gen Psychiatry 1983;40:639-45.
disorder. Article did not do justice to available research data.
154. Woody GE, McLellan AT, Luborsky L et al. Twelve-month follow- up of psychotherapy for opiate dependence. Am J Psychiatry 1987; 174. Doering S, Horz S, Rentrop M et al. Transference-focused psy- chotherapy v. treatment by community psychotherapists for bor- 155. Luborsky L, McLellan AT, Woody GE et al. Therapist success derline personality disorder: randomised controlled trial. Br J and its determinants. Arch Gen Psychiatry 1985;42:602-11.
175. Hellerstein DJ, Rosenthal RN, Pinsker H et al. A randomized 192. Guthrie E, Moorey J, Margison F. Cost-effectiveness of brief prospective study comparing supportive and dynamic therapies.
psychodynamic-interpersonal therapy in high utilizers of psychi- Outcome and alliance. J Psychother Pract Res 1998;7:261-71.
atric services. Arch Gen Psychiatry 1999;56:519-26.
176. Vinnars B, Barber JP, Noren K et al. Manualized supportive- 193. Muran JC, Safran JD. A relational approach to psychotherapy.
expressive psychotherapy versus nonmanualized community- In: Magnavita JJ (ed). Comprehensive handbook of psychother- delivered psychodynamic therapy for patients with personality apy: psychodynamic/object relations. Chichester: Wiley, 2002: disorders: bridging efficacy and effectiveness. Am J Psychiatry 194. Clarkin JF, Levy KN, Lenzenweger MF et al. The Personality 177. Svartberg M, Stiles TC, Seltzer MH. Randomized, controlled tri- Disorders Institute/Borderline Personality Disorder Research al of the effectiveness of short-term dynamic psychotherapy and Foundation randomized control trial for borderline personality cognitive therapy for cluster C personality disorders. Am J Psy- disorder: rationale, methods, and patient characteristics. J Pers 178. Muran JC, Samstag LW, Safran J et al. Evaluating an alliance- 195. Pollack J, Flegenheimer W, Winston A. Brief adaptive psychother- focused treatment for personality disorders. Psychotherapy: Theo- apy. In: Crits-Christoph P, Barber J (eds). Handbook of short-term ry, Research, Practice, Training 2005;42:532-45.
dynamic psychotherapy. New York: Basic Books, 1991:199-219.
179. Clarkin J, Levy KN, Lenzenweger MF et al. Evaluating three treat- 196. Bateman AW, Gunderson J, Mulder R. Treatment of personality ments for borderline personality disorder: a multiwave study. Am disorder. Lancet 2015;385:735-43.
J Psychiatry 2007;164:922-8.
197. Bhar SS, Thombs BD, Pignotti M et al. Is longer-term psychody- 180. Levy KN, Meehan KB, Kelly KM et al. Change in attachment namic psychotherapy more effective than shorter-term thera- patterns and reflective function in a randomized control trial of pies? Review and critique of the evidence. Psychother Psycho- transference-focused psychotherapy for borderline personality som 2010;79:208-16.
disorder. J Consult Clin Psychol 2006;74:1027-40.
198. Smit Y, Huibers MJ, Ioannidis JP et al. The effectiveness of long- 181. Bateman AW, Fonagy P. Randomized controlled trial of outpa- term psychoanalytic psychotherapy – a meta-analysis of ran- tient mentalization-based treatment versus structured clinical domized controlled trials. Clin Psychol Rev 2012;32:81-92.
management for borderline personality disorder. Am J Psychia- 199. Levy KN, Ehrenthal JC, Yeomans FE et al. The efficacy of psy- chotherapy: focus on psychodynamic psychotherapy as an exam- 182. Bateman A, Fonagy P. Impact of clinical severity on outcomes of ple. Psychodyn Psychiatry 2014;42:377-421.
mentalisation-based treatment for borderline personality disor- 200. Jones C, Hacker D, Cormac I et al. Cognitive behaviour therapy der. Br J Psychiatry 2013;203:221-7.
versus other psychosocial treatments for schizophrenia. Cochrane 183. Jørgensen CR, Freund C, Boye R et al. Outcome of mentalization- Database Syst Rev 2012;4:CD008712.
based and supportive psychotherapy in patients with borderline 201. Shedler J. The efficacy of psychodynamic psychotherapy. Am personality disorder: a randomized trial. Acta Psychiatr Scand 202. Luborsky L, Diguer L, Seligman DA et al. The researcher's own 184. Jørgensen CR, Bøye R, Andersen D et al. Eighteen months post- therapy allegiances: a ‘wild card' in comparisons of treatment treatment naturalistic follow-up study of mentalization-based efficacy. Clin Psychol Sci Pract 1999;6:95-106.
therapy and supportive group treatment of borderline personali- 203. Chambless DL, Hollon SD. Defining empirically supported ther- ty disorder: clinical outcomes and functioning. Nord Psychol apies. J Consult Clin Psychol 1998;66:7-18.
204. Cuthbert BN. The RDoC framework: facilitating transition from 185. Giesen-Bloo J, van Dyck R, Spinhoven P et al. Outpatient psy- ICD/DSM to dimensional approaches that integrate neurosci- chotherapy for borderline personality disorder: randomized trial ence and psychopathology. World Psychiatry 2014;13:28-35.
of schema-focused therapy vs transference-focused psychothera- 205. Fulford KW, Bortolotti L, Broome M. Taking the long view: an py. Arch Gen Psychiatry 2006;63:649-58.
emerging framework for translational psychiatric science. World 186. Kvarstein EH, Pedersen G, Urnes O et al. Changing from a tradi- tional psychodynamic treatment programme to mentalization- 206. Keshavan MS, Ongur D. The journey from RDC/DSM diagno- based treatment for patients with borderline personality disorder ses toward RDoC dimensions. World Psychiatry 2014;13:44-6.
– does it make a difference? Psychol Psychother 2015;88:71-86.
207. Caspi A, Houts RM, Belsky DW et al. The p factor: one general 187. Gunderson J, Links PL. Handbook of good psychiatric manage- psychopathology factor in the structure of psychiatric disorders? ment (GPM) for borderline patients. Washington: American Psy- Clin Psychol Sci 2013;2:119-37.
chiatric Press, 2014.
208. Patalay P, Fonagy P, Deighton J et al. A general psychopathology 188. McMain SF, Links PS, Gnam WH et al. A randomized trial of factor in early adolescence. Br J Psychiatry (in press).
dialectical behavior therapy versus general psychiatric manage- 209. Blatt SJ, Luyten P. A structural-developmental psychodynamic ment for borderline personality disorder. Am J Psychiatry 2009; approach to psychopathology: two polarities of experience across the life span. Dev Psychopathol 2009;21:793-814.
189. McMain SF, Guimond T, Streiner DL et al. Dialectical behavior 210. Luyten P, Blatt SJ. Interpersonal relatedness and self-definition therapy compared with general psychiatric management for bor- in normal and disrupted personality development: retrospect derline personality disorder: clinical outcomes and functioning and prospect. Am Psychol 2013;68:172-83.
over a 2-year follow-up. Am J Psychiatry 2012;169:650-61.
211. Luyten P, Blatt SJ, Fonagy P. Impairments in self structures in 190. Leichsenring F, Abbass A, Luyten P et al. The emerging evidence depression and suicide in psychodynamic and cognitive behav- for long-term psychodynamic therapy. Psychodyn Psychiatry ioral approaches: implications for clinical practice and research.
Int J Cogn Ther 2013;6:265-79.
191. Leichsenring F, Rabung S. Long-term psychodynamic psycho- therapy in complex mental disorders: update of a meta-analysis.
DOI 10.1002/wps.20235 Br J Psychiatry 2011;199:15-22.
World Psychiatry 14:2 - June 2015

Source: http://www.appops.ch/app/download/7649741214/Fonagy-2015-World_Psychiatry.pdf?t=1466491870

biogen.hu

TABLE OF CONTENTS *Perspectives from Biogen leadership For the fourth consecutive year, our global colleagues participated in ON THE COVER Biogen's Care Deeply Volunteer Day, which shattered last year's record Inspired by the new Biogen turnout with a 54-percent increase in employee participation. This worldwide logo, the front cover graphic

Sie2003

Predicción de complicaciones cardiacas utilizando Minería de Datos: Estado del Arte Norka Gómez López, René Iván González Fernández, Alejandro Rosete Suárez Resumen. El electrocardiograma (ECG) ha sido ampliamente supervivencia y la calidad de vida del paciente afectado de aplicado en el diagnóstico de enfermedades cardiovasculares. El